You can buy or sell AMPE and other stocks, options, ETFs, and crypto commission-free!
Ampio Pharmaceuticals, Inc, also called Ampio Pharmaceuticals, is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. Read More The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO. The listed name for AMPE is Ampio Pharmaceuticals, Inc.
52 Week High
52 Week Low
— per share
Expected Nov 5, Pre-Market